XML 46 R26.htm IDEA: XBRL DOCUMENT v3.26.1
Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2025
Accounting Policies [Abstract]  
Schedule of Marketable Securities

The following is a description of the valuation methodologies used for assets measured at fair value as of December 31, 2025 and December 31, 2024.

 

Marketable Securities: Valued using quoted prices in active markets for identical assets.

 

   Quoted Prices in Active Markets for Identical Assets or Liabilities
(Level 1)
   Quoted Prices for Similar Assets or Liabilities in Active Markets (Level 2)   Significant Unobservable Inputs (Level 3) 
Marketable securities at December 31, 2025  $14,801,267   $                -   $               - 
                
Marketable securities at December 31, 2024  $8,345,081   $-   $- 
Schedule of Fair Value Hierarchy of the Valuation Inputs

 

       As of December 31, 
Description  Level   2025   2024 
Liabilities              
Warrant Liabilities  3   $-   $- 
Derivative Liabilities  3   2,157,000   1,282,000 
Contingent Consideration Payable  3  

$

10,909,000

   $- 
Summary of Change in Fair Value of Warrant Liabilities

The following table sets forth a summary of the change in the fair value of the warrant liabilities that are measured at fair value on a recurring basis for the years ended December 31, 2025 and 2024:

 

   As of December 31, 
Description  2025   2024 
Balance on December 31, 2024 and 2023  $-   $867,000 
Issuance of warrants reported at fair value   -    

21,992,000

 
Changes in fair value of warrant liabilities   -    4,410,000 
Reclassification of warrant liability to equity upon warrant modification   -    (27,269,000)
Balance on December 31,  $-   $- 
Summary of Change in Fair Value of Derivative Liabilities

The following table sets forth a summary of the change in the fair value of the derivative liabilities that are measured at fair value on a recurring basis for the years ended December 31, 2025 and 2024:

 

   As of December 31, 
Description  2025   2024 
Balance on December 31, 2024 and 2023  $1,303,000   $61,000 
Issuance of derivatives reported at fair value   1,837,000    854,000 
Changes in fair value of derivative liabilities   (983,000)   (388,000)
Balance on December 31,  $2,157,000   $1,303,000 
Schedule of Change in Fair Value of Contingent Consideration

The following table sets forth a summary of the change in the fair value of the contingent consideration payable that is measured at fair value on a recurring basis for the years ended December 31, 2025 and 2024:

   As of December 31, 
Description  2025   2024 
Balance on December 31, 2024 and 2023  $-    - 
Issuance of Contingent Consideration   9,380,000    - 
Change in the fair value of Contingent Consideration   1,529,000      
Balance on December 31,  $10,909,000    - 
Schedule of Estimated Useful Lives of Property Plant and Equipment

The estimated useful lives for the current and comparative periods are as follows:

 

    Useful Life
    (in years)
Plant and equipment   5-12
Furniture and fixtures   5-10
Computer equipment & software   3-5
Leasehold Improvements   Shorter of the remaining lease or estimated useful life
Schedule of Estimated Useful Lives of Intangible Assets

Amortization is recognized on a straight-line basis over the estimated useful lives of intangible assets, other than goodwill, from the date that they are available for use. The estimated useful lives for the current and comparative periods are as follows:

 

    Useful Life
    (in years)
Patents and trademarks   12-17
Schedule of Condensed Consolidated Balance Sheet Information Related to Operating Lease

Lease expense for operating leases consists of the lease payments plus any initial direct costs and is recognized on a straight-line basis over the lease term.

 

The Company’s operating leases are comprised of the 2024 Baltimore Lease and the 2021 Baltimore Lease on the Consolidated Balance Sheets. The information related to these leases are presented below:

 

Balance Sheet Location  Lease    Lease  
   As of December 31, 2025  As of December 31, 2024 
   2024 Baltimore    2024 Baltimore  
Balance Sheet Location  Lease    Lease  
Operating Lease                     
Lease Right of Use  $-    $10,579  
Lease Payable, current   -     10,579  
Lease Payable - net of current   -     -  
Schedule of Lease Expense

The following provides details of the Company’s lease expense:

 

Lease Expenses   Lease   Lease   Total   Lease   Lease   Total 
 

For the Years Ended

December 31, 2025

  

For the Years Ended

December 31, 2024

 
    2021 Baltimore   2024 Baltimore       2021 Baltimore   2024 Baltimore     
Lease Expenses   Lease   Lease   Total   Lease   Lease   Total 
Operating Leases                               
Lease Costs   $     -   $10,800   $10,800   $18,672   $21,600   $40,272 
Schedule of Other Lease Information

Other information as of December 31, 2024 related to leases is presented below:

Other Information  Lease   Lease   Lease   Total 
   Other Lease Information 
   Platt Street   2021 Baltimore   2024 Baltimore     
Other Information  Lease   Lease   Lease   Total 
Operating Leases                    
Operating cash used  $-   $18,672   $21,600   $40,272 
Average remaining lease term   -    -    4    4 
Average discount rate   10.0%   10.0%   10.0%   10.0%
Schedule of Operating Lease Minimum Lease Payments

As of December 31, 2024, the annual minimum lease payments of the Company’s operating lease liabilities were as follows:

 

Schedule of Operating Lease Minimum Lease Payments

   Platt Street   2021 Baltimore   2024 Baltimore     
   Annual Minimum Lease Payments 
   Platt Street   2021 Baltimore   2024 Baltimore     
   Lease   Lease   Lease   Total 
For Years Ending December 31,                    
2024   -    -    -   $- 
2025   -    -    10,800    10,800 
Total future minimum lease payments, undiscounted  $-   $-   $10,800   $10,800 
Less: Imputed interest   -    -    221    221 
Present value of future minimum lease payments  $-   $-   $10,579   $10,579 
Schedule of Weighted Average Number of Shares Outstanding Earnings Per Share

As of December 31, 2025 and 2024, the following securities are excluded from the calculation of weighted average dilutive common stock because their inclusion would have been anti-dilutive:

 

   2025   2024 
  

For the Years Ended

December 31,

 
   2025   2024* 
Stock Options   11,538    1,216 
Unvested Restricted Stock Units   41,452    686 
Warrants to purchase Common Stock   5,198,756    224,956 
Series C Preferred Convertible Warrants   -    - 
Series D Preferred Convertible Stock   13    13 
Series F Preferred Convertible Stock   -    3,239,231 
Series F-1 Convertible Preferred Stock   -    3,651,539 
Series G Convertible Preferred Stock   2,601,964    4,173,077 
Series H Convertible Preferred Stock    586,718    - 
Series I Convertible Preferred Stock   188,130    - 
Total potentially antidilutive shares   8,628,571    11,290,718 

 

* 2024 values reflect the reverse split values.